Bergenin Monohydrate Attenuates Inflammatory Response via MAPK and NF-κB Pathways Against Infection.

Front Pharmacol

National Centre for Veterinary Drug Safety Evaluation, College of Veterinary Medicine, China Agricultural University, Beijing, China.

Published: May 2021

AI Article Synopsis

  • Klebsiella pneumoniae has become a significant health threat, causing conditions like pneumonia and sepsis, while drug resistance is increasing, highlighting the need for new treatments.
  • In this study, Bergenin monohydrate (Bm) was isolated and found to have anti-inflammatory properties in mice infected with Klebsiella.
  • Bm reduced lung injury and inflammatory cytokines, engaging specific cellular pathways (MAPK and NF-κB) that suggest its potential as a therapeutic agent against Klebsiella infections and a valuable addition to treatments for pneumonia.

Article Abstract

has emerged as a critical pathogen causing severe clinical problems, such as pneumonia and sepsis. Meanwhile, intensified drug resistance induced by antibiotic therapy necessitates discovering novel and active molecules from Traditional Chinese Medicine (TCM) for treatment. In this study, the isolated Bergenin monohydrate showed an anti-inflammatory effect in Klebsiella-infected mice. We initially investigated the anti-inflammatory effects and cytoprotection against oxidative stress and . Interestingly, a specific dose of Bm can effectively ameliorate lung injury and suppress the expression of inflammatory cytokines such as TNF-α, IL-6, IL-1β and PEG2. Moreover, Bm was also shown to reduced the levels of MPO, MDA and increased SOD and GSH activities. Moreover, we assessed the intracellular signaling molecules including p38, ERK, JNK, IκB, NF-κB-p65 by western blotting and verified through MAPK and NF-κB pathways inhibition experiments. These results reveal that Bm executed its effects via the classical MAPK signaling pathway and NF-κB pathway. Given its underlying anti-inflammatory effect, Bm may be used as a promising therapeutic against Klebsiella-induced infection, thus providing a benefit for the future clinical therapy of pneumonia and medicine design.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129520PMC
http://dx.doi.org/10.3389/fphar.2021.651664DOI Listing

Publication Analysis

Top Keywords

bergenin monohydrate
8
mapk nf-κb
8
nf-κb pathways
8
monohydrate attenuates
4
attenuates inflammatory
4
inflammatory response
4
response mapk
4
pathways infection
4
infection emerged
4
emerged critical
4

Similar Publications

Background: Calcium oxalate monohydrate (COM) forms the most common type of kidney stones observed in clinics, elevated levels of urinary oxalate being the principal risk factor for such an etiology. The objective of the present study was to evaluate the anti-nephrolithiatic effect of herbo-mineral formulation, Lithom.

Methods: The biochemical synthesis of COM crystals in the presence of Lithom was performed and observations were made by microscopy and Scanning Electron Microscope (SEM) based analysis for the detection of crystal size and morphology.

View Article and Find Full Text PDF

Bergenin Monohydrate Attenuates Inflammatory Response via MAPK and NF-κB Pathways Against Infection.

Front Pharmacol

May 2021

National Centre for Veterinary Drug Safety Evaluation, College of Veterinary Medicine, China Agricultural University, Beijing, China.

Article Synopsis
  • Klebsiella pneumoniae has become a significant health threat, causing conditions like pneumonia and sepsis, while drug resistance is increasing, highlighting the need for new treatments.
  • In this study, Bergenin monohydrate (Bm) was isolated and found to have anti-inflammatory properties in mice infected with Klebsiella.
  • Bm reduced lung injury and inflammatory cytokines, engaging specific cellular pathways (MAPK and NF-κB) that suggest its potential as a therapeutic agent against Klebsiella infections and a valuable addition to treatments for pneumonia.
View Article and Find Full Text PDF

Phase solubility diagrams and energy surface calculations support the solubility enhancement with low hygroscopicity of Bergenin: 4-Aminobenzamide (1: 1) cocrystal.

Int J Pharm

May 2021

Department of Hygiene Inspection & Quarantine Science, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, Guangdong 510515, China. Electronic address:

Herein, we reported a new bergenin: 4-aminobenzamide (BGN-4AM) cocrystal with significantly enhanced solubility and low hygroscopicity probed from two aspects such as phase solubility diagrams and theoretical calculations. Compared with anhydrous BGN, BGN-4AM solubilities in water and different buffer solutions (pH = 1.2, 4.

View Article and Find Full Text PDF

Bergenin monohydrate from the rhizomae of Astilbe chinensis.

Acta Crystallogr C

June 2004

Institute of Materia Medica, Zhejiang Academy of Medical Sciences, Hangzhou 310029, People's Republic of China.

The title compound, 4-methoxy-2-[(1S,2R,3S,4S,5R)-3,4,5,6-tetrahydro-3,4,5-trihydroxy-6-(hydroxymethyl)-2H-pyran-2-yl]-alpha-resorcylic acid delta-lactone monohydrate, C(14)H(16)O(9).H(2)O, is a C-glucoside of 4-O-methylgallic acid which has antiasthmatic, antitussive, anti-inflammatory, antifungal, anti-HIV and antihepatotoxic activity. The molecule is composed of three six-membered rings: an aromatic ring, a glucopyranose ring and an annellated delta-lactone ring.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!